The question of what kind of particulate matter found its way into vials of Moderna’s Covid-19 vaccine deployed in Japan may have been resolved. There is as yet...
French drugmaker Sanofi may reconsider plans to acquire Translate Bio at the conditions recently announced, the US biotech said in a filing with the US Securities and...
US biotech Moderna announced on Aug. 26 that it had completed its filing with the US Food and Drug Administration (FDA) for full marketing approval of its mRNA-based...
First to receive US approval under an Emergency Use Authorization (EUA) in late 2020, the BioNTech/Pfizer Covid-19 vaccine on Aug. 23 became the first to be fully...
US biotech Novavax, in the final stage of developing its protein-based Covid-19 vaccine, NVX-CoV2373, is adding muscle in human resources before applying to the US Food...
CV2Cov, the next-generation Covid-19 vaccine under development by German biotech CureVac and UK drugs giant GSK, outperformed CureVac’s first-generation Covid shot in...
As the delta variant of the coronavirus tears through the US, pushing both new and breakthrough infections higher, the US Centers for Disease Control (CDC) has now come...
US biotech Amgen is planning to spend $550 million on building a new biologics manufacturing plant in Holly Springs, Wake County in North Carolina. Construction is...
As it continues to grapple with documentation issues, US biotech Novavax has again altered its timeline for seeking Emergency Use Authorization (EUA) from the US Food and...
US biotech Regeneron is planning to invest roughly $1.8 billion over six years to expand its research, preclinical manufacturing and support facilities at its Westchester...
